RXO (NYSE:RXO – Get Free Report) had its price objective cut by equities researchers at Susquehanna from $18.00 to $13.00 in a report issued on Wednesday,Benzinga reports. The firm currently has a “negative” rating on the stock. Susquehanna’s price objective would indicate a potential downside of 32.19% from the company’s current price.
Several other analysts have also commented on RXO. Barclays cut their target price on shares of RXO from $32.00 to $30.00 and set an “overweight” rating for the company in a research note on Friday, January 17th. Deutsche Bank Aktiengesellschaft initiated coverage on RXO in a research note on Friday, March 7th. They set a “hold” rating and a $19.00 price objective for the company. Morgan Stanley cut their target price on RXO from $27.00 to $25.00 and set an “equal weight” rating on the stock in a research report on Thursday, February 6th. Stifel Nicolaus decreased their price target on RXO from $27.00 to $24.00 and set a “hold” rating for the company in a research report on Thursday, February 6th. Finally, Benchmark reissued a “hold” rating on shares of RXO in a research note on Wednesday, January 15th. Two analysts have rated the stock with a sell rating, eleven have issued a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $25.87.
Check Out Our Latest Stock Analysis on RXO
RXO Stock Up 0.7 %
RXO (NYSE:RXO – Get Free Report) last released its earnings results on Wednesday, February 5th. The company reported $0.06 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.06. RXO had a positive return on equity of 1.53% and a negative net margin of 6.26%. Equities analysts expect that RXO will post 0.31 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
A number of institutional investors have recently bought and sold shares of RXO. Wellington Management Group LLP increased its holdings in RXO by 24.8% during the 4th quarter. Wellington Management Group LLP now owns 1,952,884 shares of the company’s stock worth $46,557,000 after purchasing an additional 387,766 shares in the last quarter. Wealth Enhancement Advisory Services LLC raised its stake in shares of RXO by 48.0% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 18,115 shares of the company’s stock worth $432,000 after purchasing an additional 5,874 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in RXO in the fourth quarter worth $3,738,000. Mackenzie Financial Corp boosted its holdings in RXO by 37.2% in the 4th quarter. Mackenzie Financial Corp now owns 9,967 shares of the company’s stock worth $238,000 after buying an additional 2,700 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in shares of RXO by 15.3% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 285,504 shares of the company’s stock valued at $6,806,000 after acquiring an additional 37,916 shares during the period. Institutional investors and hedge funds own 92.73% of the company’s stock.
RXO Company Profile
RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.
Read More
- Five stocks we like better than RXO
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Palantir Setting Up to Be a Big Winner With New Defense Spending
- How to Profit From Value Investing
- Advanced Micro Devices Can Double in Price: Here’s Why
- Are Penny Stocks a Good Fit for Your Portfolio?
- How Disney’s Experiences Segment Can Restore the House of Mouse
Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.